Range Cancer Therapeutics ETF
$9.02
+0.00 (+0.00%)
Price as of Oct 15, 2026 market close
Performance
- 1 Month
- +0.0%
- 3 Months
- +0.0%
- YTD
- +0.0%
- 1 Year
- -26.1%
- 3 Year annualized
- -4.4%
- 5 Year annualized
- -19.7%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 26.4%
- Largest decline max drawdown, last 5 years
- -71.7%
- Risk-adjusted return Sharpe ratio, 1-year
- -1.01
Own CNCR?
See how CNCR contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.